Predictive factors associated with the progression of large-joint destruction in patients with rheumatoid arthritis after biologic therapy: A <b><i>post-hoc</i></b> analysis using FDG-PET/CT and the ARASHI (assessment of rheumatoid arthritis by scoring of large-joint destruction and healing in radiographic imaging) scoring method

Abstract

The ARASHI score may allow more detailed evaluation of large joints than the Larsen method. Joint destruction is likely to have progressed at 3 years in large joints, which had a higher SUVmax at the initiation of biologics.